Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,074 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Where is academic medicine going? Part 2. Academic career and patient care.
Bahna SL, Assa'ad AH, Bellanti JA, Bernstein DI, Davis CM, Greenberger PA, Wood RA. Bahna SL, et al. Among authors: davis cm. Ann Allergy Asthma Immunol. 2024 Jun 21:S1081-1206(24)00369-7. doi: 10.1016/j.anai.2024.06.015. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 38909982 No abstract available.
Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients.
Mathew D, Marmarelis ME, Foley C, Bauml JM, Ye D, Ghinnagow R, Ngiow SF, Klapholz M, Jun S, Zhang Z, Zorc R, Davis CW, Diehn M, Giles JR, Huang AC, Hwang WT, Zhang NR, Schoenfeld AJ, Carpenter EL, Langer CJ, Wherry EJ, Minn AJ. Mathew D, et al. Among authors: davis cw. Science. 2024 Jun 21;384(6702):eadf1329. doi: 10.1126/science.adf1329. Epub 2024 Jun 21. Science. 2024. PMID: 38900877 Clinical Trial.
Where is academic medicine going? Part 1. Medical education and research.
Bahna SL, Assa'ad AH, Bellanti JA, Bernstein DI, Davis CM, Greenberger PA, Wood RA. Bahna SL, et al. Among authors: davis cm. Ann Allergy Asthma Immunol. 2024 Jun 17:S1081-1206(24)00368-5. doi: 10.1016/j.anai.2024.06.017. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 38897403 No abstract available.
Hepatitis C virus diversity and treatment outcomes in Benin: a prospective cohort study.
Ahovègbé L, Shah R, Kpossou AR, Davis C, Niebel M, Filipe A, Goldstein E, Alassan KS, Keke R, Sehonou J, Kodjoh N, Gbedo SE, Ray S, Wilkie C, Vattipally S, Tong L, Kamba PF, Gbenoudon SJ, Gunson R, Ogwang P, Thomson EC. Ahovègbé L, et al. Among authors: davis c. Lancet Microbe. 2024 Jun 15:S2666-5247(24)00041-7. doi: 10.1016/S2666-5247(24)00041-7. Online ahead of print. Lancet Microbe. 2024. PMID: 38889738 Free article.
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.
Stieglitz E, Lee AG, Angus SP, Davis C, Barkauskas DA, Hall D, Kogan SC, Meyer J, Rhodes SD, Tasian SK, Xuei X, Shannon K, Loh ML, Fox E, Weigel BJ. Stieglitz E, et al. Among authors: davis c. Cancer Discov. 2024 Jun 11:OF1-OF9. doi: 10.1158/2159-8290.CD-23-1376. Online ahead of print. Cancer Discov. 2024. PMID: 38867349
7,074 results